| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.79B | 20.61B | 22.10B | 21.26B | 21.10B | 18.72B |
| Gross Profit | 13.11B | 8.67B | 6.67B | 13.20B | 12.43B | 11.50B |
| EBITDA | 3.73B | 4.31B | 4.12B | 4.30B | 3.77B | 4.23B |
| Net Income | 1.78B | 1.86B | 1.86B | 1.93B | 1.60B | 1.76B |
Balance Sheet | ||||||
| Total Assets | 35.35B | 36.12B | 38.25B | 35.47B | 33.26B | 33.71B |
| Cash, Cash Equivalents and Short-Term Investments | 1.80B | 2.63B | 3.22B | 3.30B | 1.47B | 3.13B |
| Total Debt | 8.64B | 6.92B | 9.47B | 8.62B | 7.11B | 7.97B |
| Total Liabilities | 16.80B | 16.83B | 18.28B | 17.10B | 15.63B | 17.05B |
| Stockholders Equity | 17.52B | 18.16B | 18.80B | 17.24B | 16.54B | 15.44B |
Cash Flow | ||||||
| Free Cash Flow | 2.05B | 1.82B | 1.99B | 1.88B | 1.08B | 976.50M |
| Operating Cash Flow | 3.24B | 3.13B | 3.38B | 3.21B | 2.42B | 2.40B |
| Investing Cash Flow | -1.58B | -2.13B | -1.86B | -1.48B | -1.48B | 619.80M |
| Financing Cash Flow | -1.07B | -1.49B | -1.55B | 134.60M | -2.54B | -2.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $36.78B | 34.81 | 12.79% | 0.67% | 6.54% | 32.48% | |
73 Outperform | $17.22B | 1.73 | 10.45% | 0.74% | -6.34% | 210.97% | |
72 Outperform | $36.10B | 33.02 | 11.90% | 0.51% | 1.99% | -41.08% | |
70 Outperform | $36.10B | 21.47 | 7.23% | ― | ― | ― | |
70 Outperform | $5.84B | 16.19 | 28.78% | 0.47% | 1.50% | -4.44% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |